Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2021; 11(7): 146-152


Effect Nigella sativa extract for balancing immune response in pristane induced lupus mice model

Theofilus Guritno, Wisnu Barlianto, Desy Wulandari, Winna Adelia Amru.




Abstract
Cited by 2 Articles

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with wide manifestations that require long-term treatment. Current treatment has not shown a satisfying result and still yields some side effects. Nigella sativa (NS) has anti-inflammatory and immunomodulatory effects and thus has the potential to improve SLE symptoms. This study aims to understand the NS effect on the level of anti-dsDNA and Treg percentage in pristane-induced lupus (PIL) mice. Anti-dsDNA has an important role in diagnosing and prognosing SLE with high specificity. Treg has been known to be disturbed in SLE. This is a true experimental, randomized posttest only controlled group design with 25 female Bagg and Albino/c mice as the subject, divided into five groups: negative control/K(−)/healthy mice, positive control/K(+)/PIL mice, and three treatment groups (three different doses of NS, 1.2, 2.4, and 4.8 g/kgBW/day). AntidsDNA analysis was conducted using enzyme-linked immunosorbent assay and Treg using flow cytometry. Treatment group 4.8 g/kgBW/day has significantly lower anti-dsDNA and significantly higher Treg than K(+) (p < 0.01). Linear regression test showed that escalation of NS dose is correlated with the decrease of anti-dsDNA and increase of Treg in PIL mice. Thus, NS has the potential to repair the immune function in SLE.

Key words: Nigella sativa, SLE, anti-dsDNA, Treg






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.